Stocks · News reference
Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 analyst estimate. Raises FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.553 billion-$8.635 billion
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.
Read original at benzingaTruist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
Read original at benzingaRBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.
Read original at benzingaBernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
Read original at benzinga